查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498731

魚疫苗市場，按疫苗類型、適應症、給藥途徑、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Fish Vaccines Market, By Vaccine Type, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年魚疫苗市場規模為3.824億美元，2024年至2032年複合年成長率為7.40%。

魚類疫苗市場-市場動態

水產養殖活動的增加推動魚類疫苗市場的成長

水產養殖活動的激增極大地推動了魚疫苗市場的成長。根據糧食及農業組織(FAO) 的數據，全球水產養殖產量一直在穩步成長，預計到2030 年將達到1.09 億噸。有效的健康管理實踐確保永續的產量。例如，鮭魚養殖領先國家挪威已大量採用魚類疫苗對抗傳染性鮭魚貧血症和魚類正呼腸病毒等疾病，從而提高了生產效率。這些趨勢凸顯了疫苗在維持魚類健康和支持水產養殖業蓬勃發展的關鍵角色。

魚疫苗市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 7.40% 左右的複合年成長率成長

根據疫苗類型細分，減毒疫苗預計將在 2023 年佔據最大市場佔有率

依主治細分，2023年癤病為主導類型

根據給藥途徑細分，2023年口服是領先類型

按地區分類，歐洲是 2023 年的主要收入來源

魚疫苗市場-區隔分析：

全球魚疫苗市場根據疫苗類型、適應症、給藥途徑、最終用戶和地區進行細分。

根據疫苗類型，市場分為七類：去活化疫苗、去活化疫苗、減毒疫苗、類毒素疫苗、次單位疫苗、合併疫苗和重組載體疫苗。減毒疫苗因其能有效誘發強烈且持久的免疫反應而引領魚疫苗市場。隨後出現去活化疫苗，提供安全性和穩定性。去活化疫苗、次單位疫苗和類毒素疫苗滿足特定需求，而結合疫苗和重組載體疫苗代表了具有先進免疫技術的新興領域。

市場依適應症分為四類：癤病、弧菌病、耶爾森氏菌病、腸道敗血症。由於癤病的廣泛流行和對鮭魚的重大影響，癤病在魚疫苗市場上佔據主導地位。弧菌病隨之而來，影響全球多種魚類。耶爾森氏菌病和腸道敗血症也佔有相當大的市場佔有率，針對水產養殖中的特定細菌感染。

魚疫苗市場 - 地理洞察

歐洲引領市場，尤其是挪威和蘇格蘭等國家，因為它們擁有先進的水產養殖業和高度魚類疫苗接種做法。北美，特別是美國和加拿大，在廣泛的鮭魚和鱒魚養殖的推動下也顯示出顯著的市場成長。在亞太地區，由於水產養殖產量的增加和魚類健康管理意識的提高，中國、印度和越南等國家正在經歷快速的市場擴張。拉丁美洲、中東和非洲是新興市場，受到水產養殖基礎設施投資不斷成長以及政府促進永續養魚做法的舉措的支持。

魚疫苗市場-競爭格局：

Zoetis Inc.、Merck & Co, Inc.（透過其子公司 MSD Animal Health）、Elanco Animal Health 和 HIPRA 等領先公司透過提供針對各種魚類疾病的多樣化疫苗組合佔據市場主導地位。這些公司專注於研發，推出新的、更有效的疫苗，改進疫苗輸送方法，並透過策略合作夥伴關係和收購擴大其地理覆蓋範圍。例如，碩騰收購 Fish Vet Group 透過增強其診斷能力和疫苗產品，鞏固了其在市場上的地位。此外，公司和學術機構之間的合作也很普遍，旨在推進疫苗技術並解決新出現的魚類疾病。例如，2023 年 3 月，印度免疫學 (IIL) 與中央淡水水產養殖研究所 (CIFA) 合作，對淡水魚出血性敗血症疫苗進行商業開發。此外，規模較小的區域性參與者也透過滿足當地的特定需求和監管要求來為市場做出貢獻。

最近的發展：

2022年11月，印度免疫學公司（IIL）計畫推出魚類疫苗，標誌著其進軍水產養殖市場。該疫苗將與中央漁業教育研究所（CIFE）合作開發，用於治療淡水魚的細菌性疾病，例如柱狀桿菌病和愛德華氏菌病。

2024 年 5 月，HIPRA 宣佈在地中海地區推出 ICTHIOVAC VNN，這是一種針對鱸魚病毒性神經壞死 (VNN) 的去活化疫苗。該疫苗旨在保護鱸魚免受 VNN 的侵害，VNN 是影響該地區水產養殖業的重大疾病

目錄

第 1 章：魚疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按疫苗類型分類的魚疫苗市場片段
    • 魚疫苗市場片段（按適應症）
    • 依給藥途徑分類的魚疫苗市場片段
    • 最終用戶的魚疫苗市場片段
    • 按國家/地區分類的魚疫苗市場摘要
    • 按地區分類的魚疫苗市場片段
  • 競爭洞察

第 3 章：魚疫苗主要市場趨勢

  • 魚類疫苗市場促進因素
    • 市場促進因素的影響分析
  • 魚疫苗市場限制
    • 市場限制影響分析
  • 魚疫苗市場機會
  • 魚疫苗市場未來趨勢

第 4 章：魚疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：魚疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：魚疫苗市場格局

  • 2023 年魚疫苗市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：魚疫苗市場 - 依疫苗類型

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 去活化疫苗
    • 去活化疫苗
    • 減毒疫苗
    • 類毒素疫苗
    • 亞單位疫苗
    • 結合疫苗
    • 重組載體疫苗

第 8 章：魚疫苗市場 - 依適應症分類

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 癤病
    • 弧菌病
    • 耶爾森氏菌病
    • 腸敗血症
    • 其他

第 9 章：魚疫苗市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 注射
    • 浸沒
    • 噴
    • 口服

第 10 章：魚疫苗市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 水產養殖場
    • 孵化場
    • 研究機構

第 11 章：魚疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美魚疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疫苗類型）
    • 北美市場規模和預測（按指標）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲魚疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按疫苗類型）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區魚疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依疫苗類型）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲魚疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疫苗類型）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲魚疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疫苗類型）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 魚疫苗產業

  • 競爭儀表板
  • 公司簡介
    • Aleph Farms
    • BioMar Group
    • Ceva Sante Animale
    • Elanco Animal Health (part of Eli Lilly and Company)
    • Fish Vet Group (part of Benchmark Holdings plc)
    • HIPRA
    • Hipra Animal Health Limited
    • Intervet Inc. (part of Merck & Co., Inc.)
    • Merck Animal Health (part of Merck & Co., Inc.)
    • MSD Animal Health (part of Merck & Co., Inc.)
    • Nisseiken Co., Ltd.
    • Syndel Laboratories
    • Vaxxinova
    • Vetech Laboratories
    • Vetoquinol SA
    • Zoetis Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2900

REPORT HIGHLIGHT

Fish Vaccines Market size was valued at USD 382.40 million in 2023, expanding at a CAGR of 7.40% from 2024 to 2032.

The Fish Vaccines Market involves the development and distribution of vaccines aimed at preventing diseases in fish populations, crucial for aquaculture health management. The increasing demand for fish protein, rising aquaculture practices, and advancements in vaccine technologies are growth factors in the market. Additionally, growing awareness about sustainable aquaculture and the need to reduce antibiotic usage in fish farming further bolsters the market. However, challenges such as high vaccine development costs, regulatory hurdles, and limited access to vaccines in developing regions restrain growth. Opportunities lie in the expansion of aquaculture in emerging markets, innovation in vaccine delivery methods, and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Market Dynamics

Rising Aquaculture Activities Propel Growth in the Fish Vaccines Market

The surge in aquaculture activities is significantly driving the growth of the Fish Vaccines Market. According to the Food and Agriculture Organization (FAO), global aquaculture production has been steadily increasing and is projected to reach 109 million tonnes in 2030. This expansion is fueled by the growing demand for fish as a protein source, necessitating effective health management practices to ensure sustainable yields. For instance, Norway, a leading country in salmon farming, has seen substantial adoption of fish vaccines to combat diseases like infectious salmon anemia and piscine orthoreovirus, enhancing production efficiency. Such trends highlight the crucial role of vaccines in maintaining fish health and supporting the thriving aquaculture industry.

Fish Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Attenuated Vaccine was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Furunculosis was the leading type in 2023

Based on Route of Administration segmentation, Oral was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Fish Vaccines Market- Segmentation Analysis:

The Global Fish Vaccines Market is segmented on the basis of Vaccine Type, Indication, Route of Administration, End-User, and Region.

The market is divided into seven categories based on Vaccine Type: Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccines. Attenuated vaccines lead the Fish Vaccines Market due to their effectiveness in inducing strong and long-lasting immune responses. Inactivated vaccines follow, offering safety and stability. Killed vaccines, subunit vaccines, and toxoid vaccines cater to specific needs, while conjugate and recombinant vector vaccines represent emerging segments with advanced immunization techniques.

The market is divided into four categories based on Indication: Furunculosis, Vibriosis, Yersiniosis, and Enteric septicaemia. Furunculosis dominates the Fish Vaccines Market due to its widespread prevalence and significant impact on salmonids. Vibriosis follows, affecting various fish species globally. Yersiniosis and enteric septicaemia also hold substantial market shares, targeting specific bacterial infections in aquaculture.

Fish Vaccines Market- Geographical Insights

Europe leads the market, particularly countries like Norway and Scotland, due to their advanced aquaculture industries and high adoption of fish vaccination practices. North America, notably the United States and Canada, also shows significant market growth driven by extensive salmon and trout farming. In the Asia-Pacific region, countries such as China, India, and Vietnam are experiencing rapid market expansion due to increasing aquaculture production and rising awareness about fish health management. Latin America and the Middle East & Africa are emerging markets, supported by growing investments in aquaculture infrastructure and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Competitive Landscape:

Leading companies such as Zoetis Inc., Merck & Co., Inc. (through its subsidiary MSD Animal Health), Elanco Animal Health, and HIPRA dominate the market by offering a diverse portfolio of vaccines targeting various fish diseases. These companies focus on research and development to introduce new and more effective vaccines, improve vaccine delivery methods, and expand their geographical reach through strategic partnerships and acquisitions. For instance, Zoetis's acquisition of Fish Vet Group has strengthened its position in the market by enhancing its diagnostic capabilities and vaccine offerings. Additionally, collaboration between companies and academic institutions is prevalent, aiming to advance vaccine technology and address emerging fish diseases. For instance, in March 2023, Indian Immunologicals (IIL) partnered with the Central Institute of Freshwater Aquaculture (CIFA) for the commercial development of a vaccine against hemorrhagic septicemia in freshwater fish. Furthermore, smaller, regional players also contribute to the market by catering to specific local needs and regulatory requirements.

Recent Developments:

In November 2022, Indian Immunologicals (IIL) planned to launch a fish vaccine, marking its entry into the aquaculture market. The vaccine will be developed in partnership with the Central Institute of Fisheries Education (CIFE) for bacterial diseases in freshwater fish, such as Columnaris Disease and Edwardsiellosis.

In May 2024, HIPRA, announced the launch of ICTHIOVAC VNN, an inactivated vaccine against Viral Nervous Necrosis (VNN) in sea bass, in the Mediterranean region. This vaccine is designed to protect sea bass against VNN, a significant disease affecting the aquaculture industry in the region

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FISH VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aleph Farms

BioMar Group

Ceva Sante Animale

Elanco Animal Health (part of Eli Lilly and Company)

Fish Vet Group (part of Benchmark Holdings plc)

HIPRA

Hipra Animal Health Limited

Intervet Inc. (part of Merck & Co., Inc.)

Merck Animal Health (part of Merck & Co., Inc.)

MSD Animal Health (part of Merck & Co., Inc.)

Nisseiken Co., Ltd.

Syndel Laboratories

Vaxxinova

Vetech Laboratories

Vetoquinol S.A.

Zoetis Inc.

Others

GLOBAL FISH VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines

GLOBAL FISH VACCINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Furunculosis
  • Vibriosis
  • Yersiniosis
  • Enteric septicaemia
  • Others

GLOBAL FISH VACCINES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Injection
  • Immersion
  • Spray
  • Oral

GLOBAL FISH VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Aquaculture Farms
  • Hatcheries
  • Research Institutes

GLOBAL FISH VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fish Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fish Vaccines Market Snippet by Vaccine Type
    • 2.1.2. Fish Vaccines Market Snippet by Indication
    • 2.1.3. Fish Vaccines Market Snippet by Route of Administration
    • 2.1.4. Fish Vaccines Market Snippet by End-User
    • 2.1.5. Fish Vaccines Market Snippet by Country
    • 2.1.6. Fish Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Fish Vaccines Key Market Trends

  • 3.1. Fish Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fish Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fish Vaccines Market Opportunities
  • 3.4. Fish Vaccines Market Future Trends

4. Fish Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fish Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Fish Vaccines Market Landscape

  • 6.1. Fish Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fish Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Killed Vaccine
    • 7.1.3. Inactivated Vaccine
    • 7.1.4. Attenuated Vaccine
    • 7.1.5. Toxoid Vaccine
    • 7.1.6. Subunit Vaccine
    • 7.1.7. Conjugate Vaccine
    • 7.1.8. Recombinant Vector Vaccines

8. Fish Vaccines Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Furunculosis
    • 8.1.3. Vibriosis
    • 8.1.4. Yersiniosis
    • 8.1.5. Enteric septicaemia
    • 8.1.6. Others

9. Fish Vaccines Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Injection
    • 9.1.3. Immersion
    • 9.1.4. Spray
    • 9.1.5. Oral

10. Fish Vaccines Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Aquaculture Farms
    • 10.1.3. Hatcheries
    • 10.1.4. Research Institutes

11. Fish Vaccines Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Fish Vaccines Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Fish Vaccines Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Fish Vaccines Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Fish Vaccines Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Fish Vaccines Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Fish Vaccines Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Aleph Farms
    • 12.2.2. BioMar Group
    • 12.2.3. Ceva Sante Animale
    • 12.2.4. Elanco Animal Health (part of Eli Lilly and Company)
    • 12.2.5. Fish Vet Group (part of Benchmark Holdings plc)
    • 12.2.6. HIPRA
    • 12.2.7. Hipra Animal Health Limited
    • 12.2.8. Intervet Inc. (part of Merck & Co., Inc.)
    • 12.2.9. Merck Animal Health (part of Merck & Co., Inc.)
    • 12.2.10. MSD Animal Health (part of Merck & Co., Inc.)
    • 12.2.11. Nisseiken Co., Ltd.
    • 12.2.12. Syndel Laboratories
    • 12.2.13. Vaxxinova
    • 12.2.14. Vetech Laboratories
    • 12.2.15. Vetoquinol S.A.
    • 12.2.16. Zoetis Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Fish Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Fish Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Fish Vaccines Market, by Indication 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Fish Vaccines Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Fish Vaccines Market, by End-User 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Fish Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by End-User, 2019-2032 (USD Million)